PCR70 Avalglucosidase Alfa (AVA) Improves Symptoms and Functioning in Late-Onset Pompe Disease (LOPD) Patients vs Alglucosidase Alfa (ALG): Post-Hoc Analyses of Patient-Reported Outcomes (PROs) From COMET Trial

Autor:	A Toscano, AT van der Ploeg, KI Berger, MM Dimachkie, B Schoser, C Gwaltney, J Msihid, A Hamed, N Thibault, L Pollissard, PS Kishnani
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S403
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.09.2005
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::610f6b89a38d23178460858f32be7ecc https://doi.org/10.1016/j.jval.2022.09.2005 Zobrazit plný text záznamu Full Text from ScienceDirect